Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 16 | 2026 | 280 | 3.410 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2020 | 1211 | 1.550 |
Why?
|
| Diabetes Mellitus, Type 2 | 10 | 2026 | 1437 | 1.290 |
Why?
|
| Brain | 11 | 2026 | 966 | 1.140 |
Why?
|
| Dementia | 7 | 2026 | 246 | 1.110 |
Why?
|
| Aged | 42 | 2026 | 10249 | 0.930 |
Why?
|
| Artificial Intelligence | 3 | 2013 | 64 | 0.800 |
Why?
|
| Risk Assessment | 3 | 2018 | 1423 | 0.740 |
Why?
|
| Female | 47 | 2026 | 19935 | 0.690 |
Why?
|
| Humans | 58 | 2026 | 32262 | 0.670 |
Why?
|
| Diet Therapy | 2 | 2020 | 17 | 0.660 |
Why?
|
| Aged, 80 and over | 23 | 2026 | 3893 | 0.610 |
Why?
|
| DNA Methylation | 3 | 2025 | 144 | 0.600 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2020 | 52 | 0.600 |
Why?
|
| Aging | 8 | 2025 | 942 | 0.600 |
Why?
|
| Databases, Factual | 2 | 2018 | 367 | 0.590 |
Why?
|
| Postmenopause | 6 | 2026 | 424 | 0.580 |
Why?
|
| Exercise Therapy | 2 | 2020 | 249 | 0.560 |
Why?
|
| Oxygen | 2 | 2009 | 138 | 0.530 |
Why?
|
| Nerve Net | 2 | 2016 | 137 | 0.520 |
Why?
|
| Metabolomics | 3 | 2017 | 63 | 0.520 |
Why?
|
| Cognition | 8 | 2026 | 547 | 0.490 |
Why?
|
| Risk Reduction Behavior | 1 | 2016 | 117 | 0.470 |
Why?
|
| Body Weight | 2 | 2020 | 323 | 0.470 |
Why?
|
| Proteomics | 3 | 2026 | 97 | 0.460 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 143 | 0.450 |
Why?
|
| Male | 29 | 2026 | 19429 | 0.450 |
Why?
|
| Middle Aged | 23 | 2026 | 11837 | 0.430 |
Why?
|
| Cardiovascular Diseases | 5 | 2024 | 1159 | 0.420 |
Why?
|
| Brain Mapping | 5 | 2011 | 190 | 0.400 |
Why?
|
| Diabetic Retinopathy | 1 | 2014 | 72 | 0.400 |
Why?
|
| Cerebrovascular Circulation | 3 | 2017 | 92 | 0.400 |
Why?
|
| Apolipoprotein E4 | 3 | 2024 | 56 | 0.400 |
Why?
|
| Women's Health | 6 | 2024 | 230 | 0.390 |
Why?
|
| Algorithms | 7 | 2020 | 536 | 0.390 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2011 | 232 | 0.370 |
Why?
|
| tau Proteins | 4 | 2026 | 39 | 0.360 |
Why?
|
| Follow-Up Studies | 7 | 2018 | 2238 | 0.350 |
Why?
|
| Risk Factors | 12 | 2026 | 3933 | 0.350 |
Why?
|
| Apolipoproteins E | 4 | 2026 | 87 | 0.340 |
Why?
|
| Incidence | 8 | 2026 | 1241 | 0.340 |
Why?
|
| Coronary Disease | 3 | 2024 | 226 | 0.330 |
Why?
|
| Cognition Disorders | 4 | 2019 | 349 | 0.330 |
Why?
|
| Air Pollution | 2 | 2024 | 15 | 0.320 |
Why?
|
| Particulate Matter | 3 | 2024 | 32 | 0.320 |
Why?
|
| Estrogens | 1 | 2011 | 194 | 0.300 |
Why?
|
| Models, Theoretical | 2 | 2016 | 139 | 0.300 |
Why?
|
| Life Style | 3 | 2026 | 394 | 0.300 |
Why?
|
| Longitudinal Studies | 7 | 2026 | 759 | 0.300 |
Why?
|
| Behavior Therapy | 2 | 2020 | 102 | 0.280 |
Why?
|
| Hemodynamics | 1 | 2009 | 164 | 0.280 |
Why?
|
| Exercise | 4 | 2021 | 605 | 0.260 |
Why?
|
| Hormone Replacement Therapy | 2 | 2019 | 94 | 0.260 |
Why?
|
| Epigenesis, Genetic | 2 | 2025 | 108 | 0.250 |
Why?
|
| Models, Biological | 1 | 2009 | 408 | 0.250 |
Why?
|
| Aldosterone | 2 | 2017 | 26 | 0.250 |
Why?
|
| Memory Disorders | 2 | 2018 | 49 | 0.240 |
Why?
|
| Proteome | 1 | 2026 | 41 | 0.240 |
Why?
|
| Genome-Wide Association Study | 3 | 2024 | 543 | 0.240 |
Why?
|
| Renin | 2 | 2017 | 107 | 0.240 |
Why?
|
| Software | 1 | 2006 | 124 | 0.240 |
Why?
|
| Geriatric Assessment | 2 | 2018 | 335 | 0.240 |
Why?
|
| Adult | 14 | 2026 | 9252 | 0.230 |
Why?
|
| Cohort Studies | 8 | 2026 | 1839 | 0.230 |
Why?
|
| Environmental Exposure | 3 | 2024 | 60 | 0.230 |
Why?
|
| Breast Feeding | 1 | 2026 | 47 | 0.230 |
Why?
|
| Automobile Driving | 1 | 2025 | 25 | 0.220 |
Why?
|
| Prediabetic State | 1 | 2026 | 76 | 0.220 |
Why?
|
| Estrogens, Conjugated (USP) | 2 | 2016 | 157 | 0.220 |
Why?
|
| Multifactorial Inheritance | 1 | 2024 | 24 | 0.210 |
Why?
|
| Wrist | 2 | 2021 | 44 | 0.210 |
Why?
|
| Magnetics | 1 | 2004 | 5 | 0.210 |
Why?
|
| Tomography | 1 | 2004 | 5 | 0.210 |
Why?
|
| Weight Loss | 2 | 2017 | 410 | 0.210 |
Why?
|
| Lipid Metabolism | 1 | 2024 | 108 | 0.210 |
Why?
|
| Air Pollutants | 1 | 2024 | 26 | 0.200 |
Why?
|
| Antidepressive Agents | 1 | 2024 | 73 | 0.200 |
Why?
|
| Insulin Resistance | 2 | 2017 | 458 | 0.200 |
Why?
|
| African Americans | 4 | 2017 | 1335 | 0.200 |
Why?
|
| Nutrition Surveys | 2 | 2026 | 144 | 0.200 |
Why?
|
| Inflammation | 4 | 2024 | 507 | 0.200 |
Why?
|
| Computer Simulation | 4 | 2009 | 251 | 0.190 |
Why?
|
| Baltimore | 3 | 2018 | 50 | 0.180 |
Why?
|
| Phenotype | 1 | 2024 | 622 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2024 | 821 | 0.180 |
Why?
|
| Blood Pressure | 2 | 2024 | 864 | 0.180 |
Why?
|
| Young Adult | 8 | 2021 | 2643 | 0.170 |
Why?
|
| Logistic Models | 2 | 2013 | 743 | 0.170 |
Why?
|
| Prospective Studies | 6 | 2026 | 2315 | 0.170 |
Why?
|
| Depression | 1 | 2024 | 425 | 0.170 |
Why?
|
| United States | 7 | 2026 | 4068 | 0.170 |
Why?
|
| Coronary Artery Disease | 1 | 2024 | 427 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2019 | 81 | 0.160 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 756 | 0.160 |
Why?
|
| Brain Ischemia | 2 | 2012 | 158 | 0.150 |
Why?
|
| Diabetes Mellitus | 2 | 2020 | 390 | 0.150 |
Why?
|
| Health Care Costs | 1 | 2020 | 122 | 0.150 |
Why?
|
| C-Reactive Protein | 2 | 2019 | 227 | 0.150 |
Why?
|
| Medicare | 1 | 2020 | 218 | 0.150 |
Why?
|
| Disease Progression | 2 | 2018 | 591 | 0.140 |
Why?
|
| Lipoproteins, LDL | 1 | 2019 | 99 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2020 | 179 | 0.140 |
Why?
|
| Diabetes Complications | 1 | 2019 | 171 | 0.140 |
Why?
|
| Auditory Cortex | 2 | 2009 | 21 | 0.140 |
Why?
|
| Visual Cortex | 2 | 2009 | 46 | 0.140 |
Why?
|
| Blood | 1 | 2018 | 13 | 0.140 |
Why?
|
| Gyrus Cinguli | 2 | 2016 | 26 | 0.140 |
Why?
|
| Mass Screening | 1 | 2020 | 256 | 0.140 |
Why?
|
| Atherosclerosis | 1 | 2024 | 821 | 0.130 |
Why?
|
| Models, Psychological | 1 | 2018 | 25 | 0.130 |
Why?
|
| Metabolome | 1 | 2018 | 37 | 0.130 |
Why?
|
| Auditory Perception | 2 | 2009 | 80 | 0.130 |
Why?
|
| Cross-Sectional Studies | 3 | 2017 | 1478 | 0.130 |
Why?
|
| Lipids | 1 | 2019 | 253 | 0.130 |
Why?
|
| Cholesterol | 1 | 2019 | 262 | 0.130 |
Why?
|
| Visual Perception | 2 | 2009 | 121 | 0.130 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 17 | 0.130 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 17 | 0.130 |
Why?
|
| alpha-Macroglobulins | 1 | 2016 | 2 | 0.130 |
Why?
|
| Neoplasms | 1 | 2024 | 757 | 0.130 |
Why?
|
| Phospholipids | 1 | 2017 | 33 | 0.130 |
Why?
|
| Health Education | 1 | 2018 | 149 | 0.130 |
Why?
|
| Glucose | 1 | 2017 | 160 | 0.120 |
Why?
|
| Leptin | 1 | 2016 | 61 | 0.120 |
Why?
|
| Muscle Proteins | 1 | 2016 | 63 | 0.120 |
Why?
|
| Anthropometry | 1 | 2016 | 89 | 0.120 |
Why?
|
| Demography | 1 | 2016 | 101 | 0.120 |
Why?
|
| Waist Circumference | 1 | 2016 | 91 | 0.120 |
Why?
|
| Radiography | 2 | 2016 | 358 | 0.120 |
Why?
|
| Adiponectin | 1 | 2016 | 94 | 0.120 |
Why?
|
| Cholesterol, HDL | 1 | 2016 | 181 | 0.120 |
Why?
|
| Insulin-Secreting Cells | 1 | 2016 | 49 | 0.120 |
Why?
|
| Triglycerides | 1 | 2016 | 235 | 0.120 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 86 | 0.110 |
Why?
|
| Diet | 1 | 2017 | 383 | 0.110 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2014 | 9 | 0.110 |
Why?
|
| Renin-Angiotensin System | 1 | 2016 | 173 | 0.110 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2016 | 96 | 0.110 |
Why?
|
| Decision Trees | 1 | 2014 | 30 | 0.110 |
Why?
|
| Stroke | 2 | 2017 | 691 | 0.100 |
Why?
|
| Prognosis | 1 | 2018 | 1529 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2016 | 484 | 0.100 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2015 | 216 | 0.100 |
Why?
|
| ROC Curve | 1 | 2014 | 169 | 0.100 |
Why?
|
| Time Factors | 1 | 2018 | 2203 | 0.100 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 67 | 0.090 |
Why?
|
| Neuropsychological Tests | 3 | 2026 | 327 | 0.090 |
Why?
|
| Retinal Vessels | 1 | 2012 | 27 | 0.090 |
Why?
|
| Retinal Diseases | 1 | 2012 | 25 | 0.090 |
Why?
|
| Linear Models | 1 | 2012 | 426 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2026 | 250 | 0.090 |
Why?
|
| Horses | 1 | 2011 | 18 | 0.080 |
Why?
|
| Brain Diseases | 1 | 2011 | 31 | 0.080 |
Why?
|
| Image Enhancement | 1 | 2011 | 66 | 0.080 |
Why?
|
| Attention | 2 | 2009 | 84 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2011 | 103 | 0.080 |
Why?
|
| Obesity | 1 | 2017 | 1111 | 0.080 |
Why?
|
| Models, Neurological | 1 | 2011 | 139 | 0.080 |
Why?
|
| Energy Metabolism | 2 | 2021 | 153 | 0.080 |
Why?
|
| Peptide Fragments | 2 | 2026 | 415 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 650 | 0.070 |
Why?
|
| Perceptual Disorders | 1 | 2009 | 8 | 0.070 |
Why?
|
| Membrane Transport Proteins | 2 | 2019 | 39 | 0.070 |
Why?
|
| Organ Size | 3 | 2016 | 221 | 0.070 |
Why?
|
| Neurons | 2 | 2026 | 486 | 0.070 |
Why?
|
| Activities of Daily Living | 2 | 2021 | 246 | 0.070 |
Why?
|
| Normal Distribution | 1 | 2008 | 14 | 0.070 |
Why?
|
| Neural Inhibition | 1 | 2008 | 33 | 0.070 |
Why?
|
| Bayes Theorem | 1 | 2008 | 82 | 0.070 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2007 | 27 | 0.060 |
Why?
|
| Risk | 2 | 2019 | 305 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 132 | 0.060 |
Why?
|
| Oligodendroglia | 1 | 2026 | 5 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2006 | 99 | 0.060 |
Why?
|
| Neurofilament Proteins | 1 | 2026 | 17 | 0.060 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2026 | 44 | 0.060 |
Why?
|
| Astrocytes | 1 | 2026 | 61 | 0.060 |
Why?
|
| Metformin | 1 | 2026 | 25 | 0.060 |
Why?
|
| Microglia | 1 | 2026 | 67 | 0.060 |
Why?
|
| Adolescent | 4 | 2020 | 3509 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2026 | 193 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2026 | 186 | 0.050 |
Why?
|
| Heterozygote | 1 | 2024 | 60 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2024 | 56 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2024 | 93 | 0.050 |
Why?
|
| Electromagnetic Fields | 1 | 2004 | 26 | 0.050 |
Why?
|
| Artifacts | 1 | 2004 | 45 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2017 | 863 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2024 | 476 | 0.050 |
Why?
|
| Mortality | 1 | 2024 | 122 | 0.050 |
Why?
|
| Age Factors | 1 | 2026 | 1178 | 0.050 |
Why?
|
| Pregnancy | 1 | 2026 | 960 | 0.050 |
Why?
|
| Wrist Joint | 1 | 2021 | 56 | 0.040 |
Why?
|
| Medicare Part A | 1 | 2020 | 5 | 0.040 |
Why?
|
| Medicare Part B | 1 | 2020 | 5 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2024 | 727 | 0.040 |
Why?
|
| Medicare Part D | 1 | 2020 | 10 | 0.040 |
Why?
|
| Eligibility Determination | 1 | 2020 | 18 | 0.040 |
Why?
|
| Health Services | 1 | 2020 | 40 | 0.040 |
Why?
|
| Age of Onset | 1 | 2020 | 90 | 0.040 |
Why?
|
| Counseling | 1 | 2020 | 94 | 0.040 |
Why?
|
| Health Expenditures | 1 | 2020 | 66 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2020 | 241 | 0.040 |
Why?
|
| Apolipoprotein C-I | 1 | 2019 | 4 | 0.040 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2019 | 12 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2019 | 11 | 0.040 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2019 | 9 | 0.040 |
Why?
|
| Animals | 1 | 2011 | 8196 | 0.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2019 | 37 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2020 | 267 | 0.030 |
Why?
|
| Forecasting | 1 | 2019 | 144 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2018 | 14 | 0.030 |
Why?
|
| Problem Solving | 1 | 2018 | 26 | 0.030 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2017 | 2 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 880 | 0.030 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2017 | 7 | 0.030 |
Why?
|
| Hospitalization | 1 | 2020 | 475 | 0.030 |
Why?
|
| Acoustic Stimulation | 2 | 2009 | 121 | 0.030 |
Why?
|
| Diet Surveys | 1 | 2017 | 48 | 0.030 |
Why?
|
| Sphingomyelins | 1 | 2017 | 8 | 0.030 |
Why?
|
| Sleep | 1 | 2018 | 87 | 0.030 |
Why?
|
| Aniline Compounds | 1 | 2017 | 18 | 0.030 |
Why?
|
| Hypertension | 1 | 2024 | 980 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 2017 | 29 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 444 | 0.030 |
Why?
|
| Calcineurin | 1 | 2016 | 3 | 0.030 |
Why?
|
| Sample Size | 1 | 2017 | 38 | 0.030 |
Why?
|
| Thiazoles | 1 | 2017 | 36 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 955 | 0.030 |
Why?
|
| Fasting | 1 | 2017 | 88 | 0.030 |
Why?
|
| Amino Acids | 1 | 2017 | 52 | 0.030 |
Why?
|
| Morbidity | 1 | 2017 | 98 | 0.030 |
Why?
|
| Cause of Death | 1 | 2017 | 236 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 174 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2018 | 178 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2016 | 82 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 149 | 0.030 |
Why?
|
| Knee Prosthesis | 1 | 2016 | 18 | 0.030 |
Why?
|
| Research Design | 1 | 2018 | 316 | 0.030 |
Why?
|
| Health Status | 1 | 2018 | 356 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 245 | 0.030 |
Why?
|
| Osteoarthritis, Knee | 1 | 2016 | 71 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 1050 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 772 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 656 | 0.030 |
Why?
|
| Knee Joint | 1 | 2016 | 127 | 0.030 |
Why?
|
| Reoperation | 1 | 2016 | 247 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 478 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 466 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 544 | 0.020 |
Why?
|
| Quality of Life | 1 | 2018 | 968 | 0.020 |
Why?
|
| Reference Values | 1 | 2011 | 238 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 471 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2009 | 167 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 3408 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 2008 | 15 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2008 | 64 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2008 | 112 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2008 | 84 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2006 | 77 | 0.020 |
Why?
|
| Movement | 1 | 2006 | 61 | 0.010 |
Why?
|
| Fingers | 1 | 2006 | 75 | 0.010 |
Why?
|